Status
Conditions
Treatments
About
The purpose of this research study is to determine if a healthy Mediterranean diet containing one medium potato/day has equivalent or non-different effects on risk factors for type 2 diabetes and heart disease compared to a healthy Mediterranean diet without potatoes in adults with prediabetes. Participants will be randomly assigned to one of the test diets and be asked to consume this diet for 12 weeks (84 days). Testing will be conducted at the beginning and end of the study.
Full description
This is a 12-week, 2-arm parallel, randomized controlled feeding trial. Participants will be randomized to either a Mediterranean-style diet that includes 1 medium potato/day/2000 kcal replacing some grains , or a traditional-style Mediterranean dietary pattern without potatoes. All food will be provided for the 12-week study duration.
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
Exclusion criteria
HbA1c ≥6.5% at screening
LDL-C (calculated with the Martin-Hopkins equation) ≥190 mg/dL at screening
Hemoglobin <13.2 g/dL at screening
Fasting triglycerides >350 mg/dL at screening
-≥10% change in body weight within the 6 months prior to enrollment
Blood pressure >140/90 mmHg at screening
Type 1 or type 2 diabetes
Prescription of anti-hypertensive, lipid-lowering, or glucose-lowering drugs
Intake of supplements that affect the outcomes of interest (i.e., lipid, blood pressure, or glucose lowering; vitamin C or multi-vitamins containing vitamin C) and are unwilling to cease during the study period.
History of liver, kidney, or autoimmune disease
Prior cardiovascular event (e.g., stroke, heart attack)
Current pregnancy or intention of pregnancy within the next 6 months
Lactation within the prior 6 months
Allergy/intolerance/sensitivity/dislike of any foods in the study menus
Antibiotic use within the prior 1 month
Oral steroid use within the prior 1 month
Use of tobacco or nicotine-containing products within the past 6 months
History of cancer at any site within the past 10 years (eligible if ≥10 years without recurrence) or non-melanoma skin cancer within the past 5 years (eligible if ≥5 years without recurrence)
Participation in another clinical trial within 60 days of baseline
Currently following a restricted or weight-loss diet
Prior bariatric surgery
Intake of >14 alcoholic drinks/week and/or not willing to avoid alcohol consumption for 48 hours prior to test visits
Principal Investigator discretion related to the potential participant's ability to adhere to the study requirements, including being able to come to attend visits
Does not speak and/or understand English
Unwilling to refrain from donating blood during the study
Weight <110 lb
Primary purpose
Allocation
Interventional model
Masking
74 participants in 2 patient groups
Loading...
Central trial contact
Kristina Petersen, PhD; Stacey Meily
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal